Timothy E. Morris
Independent DirectorMr. Timothy E. Morris, also known as Tim, CPA, Ph.D., is Member of Scientific Advisory Board of Aqur Biosciences, Inc. Mr. Morris served as Chief Financial Officer at Opthea Limited since October 24, 2022. He joined the Board of Humanetics Corp. in 2021. He serves as Independent Director of Aquestive Therapeutics, Inc. from August 05, 2022. He serves as Executive Director of Humanetics Corporation and serves as its Chief Operating Officer from December 2025. Mr. Morris was CFO at Lovance Biotherapeutics Inc. He served as Chief Financial Officer and Chief Operating Officer of Humanigen, Inc since August 01, 2020 until October 23, 2022 where he focused his attention on manufacturing, supply chain, corporate development, human resources, finance, investor relations and public relations and served as Non-Executive Director since June 29, 2016 until August 03, 2020 and serves as the member of board of the Humanigen Australia PTY Ltd. and Humanigen EU Ltd. He serves as an Independent Director of DBV Technologies S.A. since March 2021. Mr. Morris served Corporate Secretary at Iovance Biotherapeutics, Inc. Mr. Morris served as the Chief Financial Officer of AcelRx Pharmaceuticals, Inc. since March 25, 2014 until June 2, 2017 and served as its Head of Business Development since April 2015 until June 2, 2017. Mr. Morris has wide professional finance and accounting experience. He has professional finance and accounting experience, including years as Chief Financial Officer of public biotechnology companies. He served as the Chief Financial Officer of Vivus Inc. from November 9, 2004 to November 5, 2013, served as its Senior Vice President of Finance & Global Corporate Development November 2004 to December 31, 2013 and served as its Secretary. He served as Vice President of Finance at Vivus Inc. since November 9, 2004. He served as Principal Accounting Officer of Vivus Inc. from November 9, 2004 to February 27, 2007. He served as an Executive Officer of VIVUS, Inc. until December 31, 2013. He served as the Chief Financial Officer of Questcor Pharmaceuticals Inc. from September 2001 to November 2004 and served as its Principal Accounting Officer. He served as Vice President of Finance and Administration for Questcor Pharmaceuticals, Inc. since September 2001 and its Interim Member of the office of the President from August 2004 to November 2004. He served as Senior Vice President of Finance, Manufacturing and Administration for Questcor Pharmaceuticals, Inc. from September 2001 to November 2004. He served as Vice President of Finance, Administration and Chief Financial Officer for InterPro Business Solutions Inc. from October 2000 to September 2001. He served as Vice President of Finance, Administration and Chief Financial Officer of Utility.com from October 1999 to October 2000 and at RiboGene, Inc., the predecessor company to Questcor, from May 1995 to October 1999. Mr. Morris serves as a Non-Executive Director of PAION Inc. He served as an Assistant Secretary of RiboGene Inc. He served as Chief Accounting Officer, Acting Chief Financial Officer and Senior Director of Finance of Glycomed Incorporated from May 1992 to May 1995. He spent many years with Ernst & Young LLP, where he focused on biotech and technology start-ups. Mr. Morris served as Chief Financial Officer of Iovance Biotherapeutics, Inc. since August 14, 2017 until June 10, 2020, served as Principal Accounting Officer since November 8, 2017 until June 10, 2020 and served as Treasurer until June 10, 2020. Mr. Morris is also the founder and has served as the Managing Member of, Aacolade Pharma, LLC. He is a Certified Public Accountant in 1996 and earned a B.S. degree, cum laude, in Business with an emphasis in Accounting from California State University, Chico. He serves as Director at Univercells SA from 2022 and serves on the board of Humanetics (private).
Positions
- Company NameAquestive Therapeutics, Inc.Stock CodeAQSTPositionIndependent DirectorColleagues
- DBDaniel BarberCEO, President & Director
- GBGregory Bailey BrownIndependent Chairman of the Board
- AEA. Ernest TothSenior VP & CFO
- LJLori J. BraenderCorporate Secretary
- CJCassie JungChief Operating Officer
- TAThomas A. ZalewskiChief Legal Officer & Chief Compliance Officer
- JSJohn Shannon CochranIndependent Vice Chairman of the Board
- JKJulie KropIndependent Director
